CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 192 filers reported holding CATALYST PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.50 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $784,013 | +26.5% | 67,067 | +45.5% | 1.31% | +92.1% |
| Q2 2023 | $619,530 | -18.9% | 46,096 | 0.0% | 0.68% | -27.3% |
| Q1 2023 | $764,272 | -7.9% | 46,096 | +3.4% | 0.94% | +15.7% |
| Q4 2022 | $829,541 | -8.5% | 44,599 | -24.8% | 0.81% | -10.2% |
| Q3 2022 | $907,000 | +14.4% | 59,301 | -47.6% | 0.90% | +23.2% |
| Q2 2022 | $793,000 | -3.6% | 113,077 | +13.8% | 0.73% | +22.6% |
| Q1 2022 | $823,000 | +36.5% | 99,322 | -51.1% | 0.60% | +234.1% |
| Q3 2020 | $603,000 | -35.7% | 203,133 | 0.0% | 0.18% | -42.8% |
| Q2 2020 | $938,000 | +19.9% | 203,133 | 0.0% | 0.31% | -4.6% |
| Q1 2020 | $782,000 | +15.9% | 203,133 | +12.9% | 0.33% | +37.8% |
| Q4 2019 | $675,000 | -28.8% | 179,868 | 0.0% | 0.24% | -34.1% |
| Q3 2019 | $948,000 | – | 179,868 | – | 0.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 208,189 | $1,726,000 | 3.48% |
| FRIESS ASSOCIATES LLC | 571,940 | $4,741,000 | 2.53% |
| GABLES CAPITAL MANAGEMENT INC. | 438,764 | $3,637,000 | 2.28% |
| Prairiewood Capital, LLC | 258,073 | $2,139,000 | 1.50% |
| Quantedge Capital Pte Ltd | 597,300 | $4,952,000 | 1.46% |
| ARMISTICE CAPITAL, LLC | 8,372,000 | $69,404,000 | 1.34% |
| SummerHaven Investment Management, LLC | 158,473 | $1,314,000 | 0.74% |
| Capital Impact Advisors, LLC | 99,322 | $823,000 | 0.60% |
| EAM Investors, LLC | 365,415 | $3,029,000 | 0.56% |
| GLOBEFLEX CAPITAL L P | 304,515 | $2,524,000 | 0.51% |